#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Shprintzen-Goldberg syndrome Cardiac failure acute Complex regional pain syndrome Narcolepsy Hyperinsulinaemic hypoglycaemia Osteopetrosis Palmoplantar pustulosis Malignant central nervous system neoplasm Stress cardiomyopathy Malignant oligodendroglioma Myxoid liposarcoma Cutaneous T-cell lymphoma stage II Heart disease congenital Metastases to peritoneum Glycogen storage disease type II More trials…

    Learn about Rare Diseases

    Angiosarcoma – Life with Disease Haemolytic uraemic syndrome – Basic Information Breast angiosarcoma metastatic – Basic Information Alport’s syndrome – Trials in Disease Mucopolysaccharidosis I – Treatment Mast cell activation syndrome – Diagnostics Systemic sclerosis pulmonary Lysosomal storage disorder Myelodysplastic syndrome Fabry’s disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cln-081 Ion440 Tiemonium Methylsulphate Zongertinib Bortezomib Alclometasone Dipropionate CLESROVIMAB Human Coagulation Factor Ii Gsk4532990A Vinorelbine Tartrate Sibeprenlimab Travoprost Lamivudine Naloxone Sodium Lactate Solution Mosliciguat MAGNESIUM ACETATE TETRAHYDRATE A/(H3N2)-LIKE VIRUS ANTIGEN Vorasidenib Liquid Paraffin More therapies…

    Learn about Your Condition

    Intervertebral disc protrusion Exposure via breast milk Leukocyte adhesion deficiency Renal cancer Asthma Gaucher's disease type III Infant sedation Juvenile psoriatic arthritis Reperfusion injury Urea cycle disorder Vaginal cancer Diabetic retinal oedema Haematological malignancy Inflammatory bowel disease Myeloproliferative neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Extending Dosing Intervals of Mepolizumab and Dupilumab for Patients with Severe Asthma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Dupilumab
    • Mepolizumab
    The Netherlands

  • Study on the Effectiveness and Safety of Treprostinil and Drug Combination for Patients with Pulmonary Arterial Hypertension (Group I)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Treprostinil
    Austria Czechia France Germany Hungary Italy +6

  • Study on the Effect of Furosemide and Amiloride Hydrochloride on Kidney Stone Fragments After Laser Treatment in Patients Undergoing Flexible Ureteroscopy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephrolithiasis
    Investigated Drugs:
    • Amiloride Hydrochloride
    • Furosemide
    France

  • Study on Trametinib, Dexamethasone, Cyclophosphamide, and Cytarabine for Children with Relapsed or Refractory Blood Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Precursor B-lymphoblastic lymphoma recurrent
    • Precursor B-lymphoblastic lymphoma refractory
    • Precursor T-lymphoblastic lymphoma/leukaemia recurrent
    Investigated Drugs:
    • Trametinib
    Austria Belgium Denmark Finland France Germany +5

  • Study on the Effectiveness of FOLFIRINOX and FOLFOX for Patients with Advanced Small Bowel Cancer Using Calcium Levofolinate, Irinotecan, and Oxaliplatin

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small intestine adenocarcinoma
    Investigated Drugs:
    • Calcium Levofolinate
    • Fluorouracil
    • Irinotecan Hydrochloride Trihydrate
    France Italy

  • Study Comparing Thymoglobulin and Grafalon for Preventing Graft Versus Host Disease in Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Treosulfan
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    Belgium France
Previous Page
1 … 535 536 537 538 539 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!